NASDAQ:BTAI

Bioxcel Therapeutics Stock Predictions

etoro logo Buy BTAI
*Your capital is at risk
$1.16
-0.0300 (-2.52%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

BTAI Prediction Chart

BTAI Predictions History

Latest community submissions for BTAI.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 5, 2025 $2.53 -6.19% $2.73 X 92.78% 0
Mar 5, 2025 Bullish $2.73 X 1
Mar 4, 2025 $3.50 -6.66% $2.70 V 70.37% 1
Mar 4, 2025 $3.59 -4.17% $2.70 V 66.90% 1
Mar 4, 2025 Bullish $2.70 V 0
Feb 24, 2025 $2.24 +5.13% $1.97 X 86.33% 0
Feb 24, 2025 $2.20 +3.21% $1.97 X 88.41% 0
Feb 24, 2025 Bullish $1.97 X 0
Feb 1, 2024 $3.17 -93.85% $3.18 V 99.56% 5
Feb 1, 2024 $3.31 -93.58% $3.18 X 96.02% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BTAI with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT BIOXCEL THERAPEUTICS INC.
BioXcel Therapeutics
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. Its commercial product, IGALMI...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE